APRI and FIB-4 in the evaluation of liver fibrosis in chronic hepatitis C patients stratified by AST level.
Yi-Hao YenFang-Ying KuoKwong-Ming KeeKuo-Chin ChangMing-Chao TsaiTsung-Hui HuSheng-Nan LuJing-Houng WangChao-Hung HungChien-Hung ChenPublished in: PloS one (2018)
We provide optimal cutoff values of both APRI and FIB-4 to predict cirrhosis stratified by AST levels, which should be more feasible compared with the single cutoff values proposed in previous studies.